At the N0–N3 stage of lymph node metastasis, MCM4/6/7/10 showed the lowest expression in N3 tumors, which significantly correlated with patient prognosis. This evidence concerns the gene MCM4 and metastatic malignant neoplasm in the lymph nodes.